Price loading...

The 2026-2031 World Outlook for Rheumatoid Arthritis Treatments

Price data last checked 105 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
04 June 2025
Listed Since
22 August 2025

Similar Products You Might Like

The 2026-2031 World Outlook for Drugs for Rheumatoid Arthritis
98% match

The 2026-2031 World Outlook for Drugs for Rheumatoid Arthritis

£885.00 24 Jan 2026
The 2026-2031 World Outlook for Anti-Inflammatory Lupus Drugs
96% match

The 2026-2031 World Outlook for Anti-Inflammatory Lupus Drugs

£885.00 22 Jan 2026
The 2026-2031 World Outlook for Amyloidosis Treatments
96% match

The 2026-2031 World Outlook for Amyloidosis Treatments

£885.00 14 Jan 2026
The 2026-2031 World Outlook for Peripheral Neuritis Treatments
96% match

The 2026-2031 World Outlook for Peripheral Neuritis Treatments

£885.00 24 Jan 2026
The 2026-2031 World Outlook for Allergic Rhinitis Treatments
96% match

The 2026-2031 World Outlook for Allergic Rhinitis Treatments

£885.00 09 Mar 2026
The 2026-2031 World Outlook for Rosacea Treatments
96% match

The 2026-2031 World Outlook for Rosacea Treatments

£885.00 25 Jan 2026
The 2026-2031 World Outlook for Topical Radiodermatitis
96% match

The 2026-2031 World Outlook for Topical Radiodermatitis

£885.00 25 Jan 2026
The 2026-2031 World Outlook for Anti-Inflammatory Scleroderma Drugs
96% match

The 2026-2031 World Outlook for Anti-Inflammatory Scleroderma Drugs

£885.00 13 Dec 2025
The 2026-2031 World Outlook for Peripheral Neuropathy Treatments
96% match

The 2026-2031 World Outlook for Peripheral Neuropathy Treatments

£885.00 20 Jan 2026
The 2026-2031 World Outlook for Cutaneous Mastocytosis Treatments
96% match

The 2026-2031 World Outlook for Cutaneous Mastocytosis Treatments

£885.00 30 Jan 2026
The 2026-2031 World Outlook for Chondroitin Sulfate
95% match

The 2026-2031 World Outlook for Chondroitin Sulfate

£885.00 06 Feb 2026
The 2026-2031 World Outlook for Autism Therapies
95% match

The 2026-2031 World Outlook for Autism Therapies

£885.00 23 Jan 2026
The 2026-2031 World Outlook for Actinic Keratosis Treatments
95% match

The 2026-2031 World Outlook for Actinic Keratosis Treatments

£885.00 26 Jan 2026
The 2026-2031 World Outlook for Antibodies
95% match

The 2026-2031 World Outlook for Antibodies

£885.00 31 Jan 2026
The 2026-2031 World Outlook for Optic Nerve Disorders Treatments
95% match

The 2026-2031 World Outlook for Optic Nerve Disorders Treatments

£885.00 11 Jan 2026
The 2026-2031 World Outlook for Dry Eye Syndrome Treatments
95% match

The 2026-2031 World Outlook for Dry Eye Syndrome Treatments

£885.00 11 Jan 2026
The 2026-2031 World Outlook for Acne Treatments
95% match

The 2026-2031 World Outlook for Acne Treatments

£885.00 14 Jan 2026
The 2026-2031 World Outlook for Antibiotics for Bovine Respiratory Disease Treatments
95% match

The 2026-2031 World Outlook for Antibiotics for Bovine Respiratory Disease Treatments

£885.00 13 Dec 2025
The 2026-2031 World Outlook for Statins
95% match

The 2026-2031 World Outlook for Statins

£885.00 29 Jan 2026
The 2026-2031 World Outlook for Anti-Aging Therapies and Services
95% match

The 2026-2031 World Outlook for Anti-Aging Therapies and Services

£885.00 29 Jan 2026
The 2026-2031 World Outlook for Antinuclear Antibody Test Assay Kits and Reagents
95% match

The 2026-2031 World Outlook for Antinuclear Antibody Test Assay Kits and Reagents

£885.00 13 Dec 2025
The 2026-2031 World Outlook for Digital Therapeutics Sales
95% match

The 2026-2031 World Outlook for Digital Therapeutics Sales

£885.00 08 Feb 2026
The 2026-2031 World Outlook for Autism Spectrum Disorder Therapeutics
95% match

The 2026-2031 World Outlook for Autism Spectrum Disorder Therapeutics

£885.00 12 Feb 2026
The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
95% match

The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments

£885.00 31 Jan 2026